top of page

Alimta 500 mg Injection

SKU Eli Lilly And Company India Pvt Ltd
Prix d’origine

339,98$

Prix promotionnel

298,07$

Alimta 500 mg Injection is an effective treatment option specifically designed for patients battling non-small cell lung cancer and malignant pleural mesothelioma. Administered by a qualified healthcare professional, this medication works by disrupting the growth of cancer cells, thereby helping to manage the progression of these serious conditions. The dosage and frequency of Alimta will be carefully determined by your physician based on your individual treatment needs and may be adjusted over time for optimal results. It is crucial to adhere strictly to your doctor’s instructions regarding administration to avoid potential complications associated with incorrect dosing. Patients should be aware that both underdosing and overdosing can lead to significant health risks. Regular monitoring during treatment is essential to ensure safety and efficacy. Always discuss any concerns or side effects with your healthcare provider to ensure the best possible outcome. Alimta stands as a vital option in the fight against these challenging cancers, contributing to improved patient care and outcomes.

Quantité

Active Pharmaceutical Ingredient

Pemetrexed 500 mg

Uses

• Alimta 500 mg injection is primarily used in the treatment of non-small cell lung cancer (NSCLC). This medication targets cancer cells, helping to slow their growth and proliferation. It is typically administered to patients who have advanced stages of NSCLC, where other treatments may not be effective. By utilizing Alimta 500 mg injection, oncologists aim to improve the overall survival rate and quality of life for these patients.
• Another significant use of Alimta 500 mg injection is in the management of malignant pleural mesothelioma. This type of cancer affects the lining of the lungs and is often associated with asbestos exposure. Alimta 500 mg injection works by disrupting the cancer cell cycle, which is crucial in treating this aggressive disease. Patients receiving Alimta 500 mg injection may experience a reduction in tumor size and improved symptoms related to their condition.
• Alimta 500 mg injection is often prescribed as part of a combination therapy regimen. This approach may include other chemotherapy agents to enhance treatment efficacy against lung cancers. By incorporating Alimta 500 mg injection, healthcare providers can tailor the therapy to better suit individual patient needs and maximize treatment outcomes. This combination strategy helps to tackle cancer from multiple angles, potentially leading to more favorable results.
• In clinical settings, Alimta 500 mg injection is administered in cycles, allowing healthcare teams to monitor patient responses closely. This strategic timing helps optimize the treatment plan and manage any necessary adjustments based on the patient’s progress. Alimta 500 mg injection is an essential component of care for patients battling advanced lung cancers, making it a vital part of contemporary oncological practices.

Benefits

Non-small cell lung cancer: Non-small cell lung cancer, a major form of lung cancer, affects people regardless of their smoking status. Alimta 500 mg Injection is proving to be a valuable tool in the fight against this disease, either as monotherapy or in combination with other medicines. This drug has considerable potency and toxicity, which underlines the importance of discussing its potential risks and benefits with your doctor. During treatment, it's advisable to avoid alcohol and to prioritize hydration by increasing fluid intake. In malignant pleural mesothelioma: Malignant pleural mesothelioma is a particularly aggressive form of cancer that typically starts in the lungs and lining of the ribs. Alimta Injection is used in combination with other medicines to treat this condition. Its primary function is to target and eliminate cancer cells by stopping their ability to multiply. By preventing the cancer from spreading to nearby areas, this treatment helps to control its progression. It's important to follow your doctor's instructions closely and ask for clarification if you're not sure.

Side Effects

Alimta 500 mg Injection may cause some adverse effects, which may vary from person to person. Some of these adverse effects are listed below.

Most Common Side Effects

• Fatigue
• Nausea
• Vomiting
• Diarrhoea
• Redness, swelling, or sores in the mouth
• Loss of appetite, sensation
• Increased skin pigmentation
• Watery and inflamed eyes, taste change
• Fever
• Muscle weakness
• Dehydration
• Constipation
• Skin rash
• Hair loss

Common Side Effects

• Infection
• Severe allergic reaction
• Breathlessness, intense chest pain, or cough with bloody sputum
• Decrease in white blood cells count
• Kidney failure
• Abnormal liver function

How To Use

Alimta 500 mg Injection will be administered by a nurse or doctor in a clinic or hospital. It is available in an injectable form that is injected into the vein. You will need to follow the doctor's instructions to the letter during the treatment.

Safety Advice

• Alcohol: It's generally recommended to avoid consuming alcohol while undergoing treatment with Alimta 500 mg Injection or any other chemotherapy medication. Alcohol can interact with certain medications, potentially affecting their effectiveness or causing adverse reactions. Additionally, alcohol consumption may exacerbate some of the side effects associated with chemotherapy, such as nausea, vomiting, and liver toxicity.
• Kidney: Caution should be exercised when considering the use of Alimta Injection in patients with renal disease. Depending on the severity of the renal condition, dose adjustments may be warranted. It is imperative to consult a physician prior to initiating this medication. In particular, the use of Alimta 500 mg Injection is discouraged in individuals with moderate to severe renal impairment in order to maintain treatment safety and efficacy. Always prioritise discussions with healthcare providers to tailor the treatment plan to individual medical requirements.
• Breastfeeding: Using Alimta 500 Injection while breastfeeding requires careful consideration. It's advisable to pause breastfeeding until the mother's treatment is finished and the drug has been fully cleared from her system.
• Liver: Alimta Injection is safe to use in patients with liver disease. No dose adjustment of Alimta 500 Injection is recommended. If you experience any side effects please consult your doctor.
• Pregnancy: Alimta 500 mg Injection should be avoided during pregnancy due to the clear evidence of potential harm to the developing fetus. However, in rare cases of life-threatening situations where the benefits outweigh the risks, a doctor may consider prescribing it. It's crucial to consult your doctor for personalized guidance regarding the use of Alimta 500 Injection during pregnancy.
• Driving: Alimta 500 mg Injection has potential side effects that may impair your ability to drive. Its tendency to cause drowsiness may impair your ability to drive a vehicle safely.

bottom of page